Eone Diagnomics Genome Center Co., Ltd.

KOSDAQ:A245620 Stock Report

Market Cap: ₩57.4b

Eone Diagnomics Genome Center Dividends and Buybacks

Dividend criteria checks 0/6

Eone Diagnomics Genome Center does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-28.3%

Buyback Yield

Total Shareholder Yield-28.3%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

There's No Escaping Eone Diagnomics Genome Center Co., Ltd.'s (KOSDAQ:245620) Muted Revenues Despite A 43% Share Price Rise

Feb 29
There's No Escaping Eone Diagnomics Genome Center Co., Ltd.'s (KOSDAQ:245620) Muted Revenues Despite A 43% Share Price Rise

Is Eone Diagnomics Genome Center (KOSDAQ:245620) Weighed On By Its Debt Load?

Apr 06
Is Eone Diagnomics Genome Center (KOSDAQ:245620) Weighed On By Its Debt Load?

If You Had Bought Eone Diagnomics Genome Center (KOSDAQ:245620) Shares A Year Ago You'd Have Earned 54% Returns

Feb 24
If You Had Bought Eone Diagnomics Genome Center (KOSDAQ:245620) Shares A Year Ago You'd Have Earned 54% Returns

Do Insiders Own Lots Of Shares In Eone Diagnomics Genome Center Co., Ltd. (KOSDAQ:245620)?

Jan 20
Do Insiders Own Lots Of Shares In Eone Diagnomics Genome Center Co., Ltd. (KOSDAQ:245620)?

Eone Diagnomics Genome Center (KOSDAQ:245620) Is Carrying A Fair Bit Of Debt

Dec 16
Eone Diagnomics Genome Center (KOSDAQ:245620) Is Carrying A Fair Bit Of Debt

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A245620's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A245620's dividend payments have been increasing.


Dividend Yield vs Market

Eone Diagnomics Genome Center Dividend Yield vs Market
How does A245620 dividend yield compare to the market?
SegmentDividend Yield
Company (A245620)n/a
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.9%
Industry Average (Life Sciences)1.0%
Analyst forecast (A245620) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A245620's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A245620's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A245620's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A245620 has not reported any payouts.


Discover strong dividend paying companies